Low-density lipoprotein (LDL) and the risk of thrombotic events in essential thrombocythemia and polycythemia vera

被引：8
|
作者：
Krecak, Ivan [1 ]
Holik, Hrvoje [2 ]
Coha, Bozena [2 ]
Peric, Martina Moric [3 ]
Zekanovic, Ivan [3 ]
Krecak, Marija Valovicic [4 ]
Gveric-Krecak, Velka [1 ]
Lucijanic, Marko [5 ,6 ]
机构：
[1] Gen Hosp Sibenik Knin Cty, Dept Internal Med, Stjepana Radica 83, Shibenik 22000, Croatia
[2] Dr Josip Bencevic Gen Hosp, Dept Internal Med, Slavonski Brod, Croatia
[3] Gen Hosp Zadar, Dept Internal Med, Zadar, Croatia
[4] Gen Hosp Sibenik Knin Cty, Dept Psychiat, Shibenik, Croatia
[5] Univ Hosp Dubrava, Zagreb, Croatia
[6] Univ Zagreb, Sch Med, Zagreb, Croatia
来源：
ANNALS OF HEMATOLOGY | 2021年 / 100卷 / 05期
关键词：
STATINS;
D O I：
10.1007/s00277-021-04431-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1335 / 1336
页数：2
相关论文
共 50 条
  • [21] Prevalence of polycythemia vera and essential thrombocythemia
    Ma, Xiaomei
    Vanasse, Gary
    Cartmel, Brenda
    Wang, Yun
    Selinger, H. Andrew
    AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (05) : 359 - 362
  • [22] THROMBOTIC RISK IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA WITH AGE LESS THAN OR EQUAL TO 60 YEARS
    Accurso, V.
    Santoro, M.
    Contrino, A. D.
    Sardo, M.
    Raso, S.
    Tarantino, G.
    Siragusa, S.
    HAEMATOLOGICA, 2019, 104 : 125 - 125
  • [23] Risk-adapted therapy in essential thrombocythemia and polycythemia vera
    Finazzi, G
    Barbui, T
    BLOOD REVIEWS, 2005, 19 (05) : 243 - 252
  • [24] Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia
    Krecak, Ivan
    Lucijanic, Marko
    Verstovsek, Srdan
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2022, 17 (05) : 155 - 169
  • [25] Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia
    Ivan Krecak
    Marko Lucijanic
    Srdan Verstovsek
    Current Hematologic Malignancy Reports, 2022, 17 : 155 - 169
  • [26] Therapy for polycythemia vera and essential thrombocythemia is driven by the cardiovascular risk
    Barbui, Tiziano
    Finazzi, Guido
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2007, 33 (04): : 321 - 329
  • [27] Leukocytosis at Diagnosis and the Risk of Subsequent Thrombosis in Low-Risk Essential Thrombocythemia and Polycythemia Vera
    Gangat, Naseema
    Wolanskyj, Alexandra
    Schwager, Susan
    Hanson, Curtis A.
    Tefferi, Ayalew
    BLOOD, 2008, 112 (11) : 618 - 618
  • [28] Management Issues and Controversies in Low-Risk Patients with Essential Thrombocythemia and Polycythemia Vera
    How, Joan
    Hobbs, Gabriela
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2021, 16 (05) : 473 - 482
  • [29] Management Issues and Controversies in Low-Risk Patients with Essential Thrombocythemia and Polycythemia Vera
    Joan How
    Gabriela Hobbs
    Current Hematologic Malignancy Reports, 2021, 16 : 473 - 482
  • [30] Low-risk polycythemia vera and essential thrombocythemia: management considerations and future directions
    Hannah Goulart
    John Mascarenhas
    Douglas Tremblay
    Annals of Hematology, 2022, 101 : 935 - 951
12345